Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Carbone

Showing results (241-250 of 266) with videos related to

Pageof 27
Sort By:
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Annals of Clinical and Translational Neurology|July 20, 2024
Objective and subjective cognitive outcomes one year after COVID-19Laura Zamarian, Verena Rass, Elisabeth Goettfried, et al.
Clinical & Experimental Metastasis|August 4, 2019
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancerFederico Carbone, Francesco Grossi, Aldo Bonaventura, et al.
Oncology Letters|August 7, 2012
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysisSara Aquino, Marino Clavio, Edoardo Rossi, et al.
European Journal of Clinical Investigation|August 14, 2021
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLCFederico Carbone, Stefano Ministrini, Aldo Bonaventura, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic SyndromeAnna Laura Cremonini, Andrea Pasta, Federico Carbone, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2019
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot studyAldo Bonaventura, Francesco Grossi, Federico Carbone, et al.
Diabetes Research and Clinical Practice|August 20, 2023
Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetesAlessandro Scuricini, Francesco Andreozzi, Cosimo Sgura, et al.
Vascular Pharmacology|April 30, 2015
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte responseFabrizio Montecucco, Sébastien Lenglet, Federico Carbone, et al.
Annals of Clinical and Translational Neurology|October 20, 2022
Cognitive dysfunction 1 year after COVID-19: evidence from eye trackingFederico Carbone, Laura Zamarian, Verena Rass, et al.
Pageof 27

Showing results (241-250 of 266) with videos related to

Sort By:
Pageof 27
European Journal of Internal Medicine|July 17, 2024
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patientsLuca Liberale, Claudia Torino, Patrizia Pizzini, et al.
Annals of Clinical and Translational Neurology|July 20, 2024
Objective and subjective cognitive outcomes one year after COVID-19Laura Zamarian, Verena Rass, Elisabeth Goettfried, et al.
Clinical & Experimental Metastasis|August 4, 2019
Baseline serum levels of osteopontin predict clinical response to treatment with nivolumab in patients with non-small cell lung cancerFederico Carbone, Francesco Grossi, Aldo Bonaventura, et al.
Oncology Letters|August 7, 2012
Therapy of Hodgkin's lymphoma in clinical practice: A retrospective long-term follow-up analysisSara Aquino, Marino Clavio, Edoardo Rossi, et al.
European Journal of Clinical Investigation|August 14, 2021
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLCFederico Carbone, Stefano Ministrini, Aldo Bonaventura, et al.
Frontiers in Molecular Biosciences|June 27, 2022
Lipoprotein(a) Modulates Carotid Atherosclerosis in Metabolic SyndromeAnna Laura Cremonini, Andrea Pasta, Federico Carbone, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2019
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot studyAldo Bonaventura, Francesco Grossi, Federico Carbone, et al.
Diabetes Research and Clinical Practice|August 20, 2023
Osteopontin levels correlate with severity of diabetic cardiomyopathy in early stage of diabetesAlessandro Scuricini, Francesco Andreozzi, Cosimo Sgura, et al.
Vascular Pharmacology|April 30, 2015
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte responseFabrizio Montecucco, Sébastien Lenglet, Federico Carbone, et al.
Annals of Clinical and Translational Neurology|October 20, 2022
Cognitive dysfunction 1 year after COVID-19: evidence from eye trackingFederico Carbone, Laura Zamarian, Verena Rass, et al.
Pageof 27